Abiomed
(NASDAQ) ABMD
This security has been delisted. This page is retained for historical reference.
ABMD News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowABMD Financials
Key Financial Metrics (TTM)
Gross Margin
81.76%
Operating Margin
36.12%
Net Income Margin
13.23%
Return on Equity
9.64%
Return on Capital
24.79%
Return on Assets
8.16%
Earnings Yield
N/A
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
N/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Shares Outstanding
N/A
Volume
N/A
Avg. Volume
N/A
Financials (TTM)
Gross Profit
$873.51M
Operating Income
$253.61M
EBITDA
$469.75M
Operating Cash Flow
$250.98M
Capital Expenditure
-$33.76M
Free Cash Flow
$217.22M
Cash & ST Invst.
$820.37M
Total Debt
$0.00
Abiomed Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonCurrently no data to display.
Quarterly Performance
Revenue
$265.92M
+7.2%
Gross Profit
$217.04M
+6.3%
Gross Margin
81.62%
N/A
Market Cap
N/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
N/A
Market Cap/Employee
N/A
N/A
Employees
2,003
N/A
Net Income
$106.13M
+86.4%
EBITDA
$226.14M
+240.4%
Quarterly Fundamentals
Total Cash
$820.37M
+26.1%
Total Debt
$0.00
N/A
Accounts Receivable
$94.48M
+5.5%
Inventory
$102.24M
+18.9%
Long Term Debt
$0.00
N/A
Short Term Debt
$0.00
-100.0%
Return on Assets
8.16%
N/A
Return on Invested Capital
24.28%
N/A
Free Cash Flow
$7.81M
-85.4%
Operating Cash Flow
$13.42M
-77.8%